site stats

Biotheranostics hologic login

WebHologic announced a $230 million deal in which it will acquire Biotheranostics, a private company that provides molecular diagnostic tests for breast and metastatic cancers. Through the purchase, Hologic aims to enhance its current work in the field of oncology with more personalized treatment and better outcomes for women. WebBreast Cancer Index™ (BCI) is the only test recognized by NCCN Clinical Practice Guidelines in Oncology (NCCN ® Guidelines) and the American Society of Clinical …

Hologic to acquire Biotheranostics for $230M - MassDevice

WebSign in or register to place Hologic product orders online (consumables only), download and view secure product documentation, search employment opportunities and set up job alerts or access training … WebAccess and use of the Biotheranostics Web site is subject to the terms and conditions set forth herein and all applicable laws, statutes, and/or regulations. Biotheranostics does not, by or through this Web site, offer for sale any products or services. Biotheranostics may revise or modify these terms and conditions from time to time. city clg science and commerce multan https://sabrinaviva.com

Hologic To Buy Biotheranostics For $230M; Top Analyst

WebJan 6, 2024 · On Monday, it announced acquisition of Somatex Medical for $64 million, a buy also in the women's health space. Hologic's $230 million valuation is roughly seven … WebJan 5, 2024 · – Transaction Accelerates Hologic’s Entry into Oncology Growth Market, Provides New Lab Capabilities – – Hologic’s Commercial Resources, Expertise in … WebIn a clinical study of 547 patients considered to be clinically low risk (T1N0), Breast Cancer Index identified ~25% as likely to benefit from extended endocrine therapy and high risk of late distant recurrence. References: 1. Referenced with permission from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines ®) for Breast ... dicted to style with gary della-bate

Breast Cancer Index

Category:News Hologic announces acquisition of Biotheranostics

Tags:Biotheranostics hologic login

Biotheranostics hologic login

Hologic to Acquire Biotheranostics, Leader in Molecular Tests …

WebBiotheranostics, Inc., A Hologic Company 8 years Senior Director, National Oncology Sales Biotheranostics, Inc., A Hologic Company Jul 2024 ... WebJan 6, 2024 · January 6, 2024 By Sean Whooley. Hologic (NSDQ: HOLX) announced that it agreed to acquire molecular diagnostic test maker Biotheranostics for approximately $230 million. Privately held, commercial ...

Biotheranostics hologic login

Did you know?

WebFeb 23, 2024 · February 23, 2024 By Sean Whooley. Hologic (NSDQ: HOLX) announced that it completed its previously announced acquisition of Biotheranostics for $230 million. Marlborough, Mass.-based Hologic last ... WebFeb 22, 2024 · MARLBOROUGH, Mass.--(BUSINESS WIRE)-- Hologic, Inc. (Nasdaq: HOLX), a global leader in women's health, has completed its previously announced …

WebCancerTYPE ID ® is performed and billed separately by NeoGenomics’ contracted reference laboratory, Biotheranostics, Inc., an independent CLIA-licensed and CAP … WebJan 5, 2024 · SPX. +1.87%. Medical technology company Hologic Inc. HOLX, +0.71% said late Tuesday it has agreed to buy privately held Biotheranostics Inc. for $230 million. Biotheranostics, which generated ...

WebJan 5, 2024 · Biotheranostics generated approximately $33 million of revenue in calendar 2024. The acquisition is expected to be slightly dilutive to Hologic’s non-GAAP earnings per share in fiscal 2024, break-even in 2024, and accretive thereafter. The acquisition is expected to close in February of 2024, subject to antitrust clearance and other customary ... WebJan 5, 2024 · MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX), a global leader in women's health, announced today that it has agreed to acquire …

http://www.biotheranostics.com/privacy-practices.html

WebThis Notice of privacy practices describes how Biotheranostics may use and disclose individuals’ health information, whether collected on our website or off-line, and is posted in compliance with HIPAA. Questions. ... Hologic, Biotheranostics, Breast Cancer Index, CancerTYPE ID and associated logos are trademarks and/or registered trademarks ... city cliff schoolWebJan 5, 2024 · MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX), a global leader in women's health, announced today that it has agreed to acquire … city climate comparison side by sidecity clientWebApr 3, 2024 · Medicare Expands Coverage for Hologic's Biotheranostics Breast Cancer Test. The firm said that the expanded coverage provides more women with access to a test that helps determine whether extended endocrine therapy is appropriate. Hologic Banking on MDx Acquisitions to Elevate Long-Term Revenue Growth. city cliffs climbing gyms 98 brigantine drhttp://www.biotheranostics.com/ city clifford simakWebFeb 22, 2024 · MARLBOROUGH, Mass.--(BUSINESS WIRE)-- Hologic, Inc. (Nasdaq: HOLX), a global leader in women's health, has completed its previously announced acquisition of molecular oncology leader Biotheranostics, Inc. for approximately $230 million.Biotheranostics develops and markets two highly differentiated molecular … dicte crime reporter season 4WebJan 5, 2024 · "Hologic’s leadership in women’s health and molecular automation will accelerate access for both of our novel, proprietary tests, translating into better clinical outcomes for cancer patients," Don Hardison, Biotheranostics’ president and CEO, said in a … dictee archibald